Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease

NCT02652741 is registered in ClinicalTrials.gov with Ethicare GmbH as lead sponsor.

NCT NCT02652741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02652741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease
Lead sponsor
Ethicare GmbH
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 31, 2016
Completion date
June 30, 2017
Enrollment
50 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, heart failure